NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, late Wednesday announced its financial results for the third quarter and year-to-date periods ended September 30, 2018. Among the highlights, the company achieved a significant operating loss decrease, recorded initial revenue from its new scientific services group and pursued accelerated development of its Ultra Shear Technology platform. “We are pleased to report that with tight fiscal oversight, our operating loss continued to decrease in FY 2018… At the same time, we continued to increase our efforts on expanding the offerings and exposure of our new Scientific Services Group; these efforts led to significant revenue generation in Q3 and for year-to-date 2018, compared to no revenue in this area in FY2017,” Joseph L. Damasio, vice president of finance and CFO of PBIO, stated in the news release. “We believe revenue will continue to climb in Scientific Services in Q4; we also have expectations of very significant revenue growth in this area for FY2019.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer